BRCA1 and BRCA2

tumor-suppressor genes thought to be linked to genetic breast and ovarian cancer.


Carcinoma in situ

a lesion observed most commonly in stratified squamous epithelium and characterized by cytological changes of the types associated with invasive carcinoma, but with the pathologic process limited to the lining epithelium and without histologic evidence of extension to adjacent structures.

CDA

Career Development Award.

CRISP

Computer Retrieval of Information on Scientific Projects.

CT scan

computed tomography scan. Works by using radiation to visually cut parts of the body in cross-sectional slices.


DHHS

Department of Health and Human Services.

Digital mammography

technique of using a dedicated electronic detector system to computerize and display the x-ray information from conventional mammography.

DOD

Department of Defense.

DOE

Department of Energy.

DROLS

Defense Research On-Line System.

DTIC

Defense Technical Information Center.

Ductal carcinoma in situ

ductal cancer cells that have not grown outside of their site of origin, sometimes referred to as precancer.

DVA

Department of Veteran Affairs.

DWHRP

Defense Women's Health Research Program.


ERBB2

V-erb avian erythroblastic leukemia viral oncogene homolog 2; also known as NEU and HER2.


FedRIP

Federal Research in Progress.

FHIT

Fragile histidine triad gene. A tumor suppressor gene mutated in lung, head and neck, intestinal, and breast cancers.


Gene

a functional unit of heredity which occupies a specific place or locus on a chromosome.


HBCU/MIs

Historically black colleges and universities and other minority institutions.

HER2

V-erb avian erythroblastic leukemia viral oncogene homolog 2; also known as ERBB2 and NEU.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement